Please log in to determine if you are eligible to purchase PT Programs.
CAP/ACMG MITOCHONDRIAL DNA DELETION SYND - IMD1
IMD1
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
Mitochondrial DNA deletion syndromes 3 Two shipments per year

Program Information

  • Three 100.0‑μL DNA specimens

Shipping Schedule

  • Shipment A: March 37
  • Shipment B: September 25